Original StudyIncidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non–Small-cell Lung Cancer
Under a Creative Commons license
open access
Keywords
Immune checkpoint inhibitor
Immunotherapy
irAEs
NSCLC
Toxicity
Cited by (0)
© 2018 The Author(s). Published by Elsevier Inc.